These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 7501662

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
    Bejanian M, Pechnick RN, Bova MP, George R.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):88-93. PubMed ID: 1677044
    [Abstract] [Full Text] [Related]

  • 3. Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligand.
    Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind JC.
    Pharmacol Biochem Behav; 1995 Apr 01; 50(4):587-92. PubMed ID: 7617705
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol; 1996 Apr 01; 48(4):379-95. PubMed ID: 9112678
    [Abstract] [Full Text] [Related]

  • 7. Sigma sites mediate DTG-evoked hypothermia in rats.
    Rawls SM, Baron DA, Geller EB, Adler MW.
    Pharmacol Biochem Behav; 2002 Nov 01; 73(4):779-86. PubMed ID: 12213522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM, O'Shea RD, Manallack DT.
    J Neurochem; 1989 Sep 01; 53(3):779-88. PubMed ID: 2569504
    [Abstract] [Full Text] [Related]

  • 13. Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.
    Shimizu I, Kawashima K, Ishii D, Oka M.
    Br J Pharmacol; 2000 Oct 01; 131(3):610-6. PubMed ID: 11015314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two subtypes of enteric non-opioid sigma receptors in guinea-pig cholinergic motor neurons.
    Coccini T, Costa LG, Manzo L, Candura SM, Iapadre N, Balestra B, Tonini M.
    Eur J Pharmacol; 1991 May 30; 198(1):105-8. PubMed ID: 1680712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW, Naper K, Pontecorvo MJ.
    Eur J Pharmacol; 1991 Jan 25; 193(1):21-7. PubMed ID: 1675607
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain.
    Hohmann AG, Matsumoto RR, Hemstreet MK, Patrick SL, Margulies JE, Hammer RP, Walker JM.
    Brain Res; 1992 Oct 16; 593(2):265-73. PubMed ID: 1450934
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.